流行与大流行病毒感染:对结核病和肺部的影响:WAidid、GTN 与 ESCMID 分枝杆菌感染研究组共识
该共识由世界传染病与免疫紊乱协会(WAidid)、全球结核病网络(GTN)及欧洲临床微生物与感染病学会(ESCMID)分枝杆菌感染研究组(ESGMYC)联合制定,写作委员会包括欧洲疾病预防控制中心公共卫生应急团队(ECDC PHE)。通过文献检索、多轮修订及德尔菲流程达成共识,讨论 MERS、SARS、HIV、甲型 H1N1 pdm/09 与 COVID-19 的流行病学与免疫学及其与结核病的相互作用,并涉及诊断、治疗和空气传播感染预防(感染控制、病毒遏制与工作场所安全)。共识指出,结核病仍是头号传染病杀手,但除结核/艾滋病毒共病外,病毒性流行/大流行与结核病的相互作用所知甚少。
要点
- 结核病仍是头号传染病杀手,但除结核/艾滋病毒共病外,病毒性流行/大流行与结核病的相互作用所知甚少。
- 共识覆盖的累及肺部的流行/大流行病毒包括 MERS、SARS、HIV、甲型 H1N1 pdm/09 与 COVID-19。
- 共识讨论上述病毒感染的流行病学与免疫学及其与结核病的相互作用。
- 共识内容涉及空气传播感染的诊断、治疗与预防,包括感染控制、病毒遏制与工作场所安全。
- 共识由 WAidid、GTN、ESCMYC 及 ECDC PHE 团队等多方国际专家经德尔菲流程与多轮修订达成。
研究设计与关键结果
- 制定机构:世界传染病与免疫紊乱协会(WAidid)、全球结核病网络(GTN)、欧洲临床微生物与感染病学会(ESCMID)分枝杆菌感染研究组(ESGMYC),写作委员会包括欧洲疾病预防控制中心公共卫生应急团队(ECDC PHE)。
- 方法:文献检索后由写作委员会与更大专家组多轮修订达成共识;由核心作者组(不含 ECDC PHE 团队)进行德尔菲流程,第一轮确定需综述/共识的领域,第二轮细化最终共识要素。
- 内容范围:MERS、SARS、HIV、甲型 H1N1 pdm/09 与 COVID-19 等累及肺部的流行/大流行病毒感染的流行病学与免疫学及其与结核病的相互作用,以及空气传播感染的诊断、治疗与预防(感染控制、病毒遏制与工作场所安全)。
证据类型、等级与局限
- 证据类型:国际专家共识文件。
- 共识经多轮修订和德尔菲流程达成。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
- 共识指出结核病仍是头号传染病杀手,但除结核/艾滋病毒共病外,病毒性流行/大流行与结核病的相互作用所知甚少。
指南或共识出处
- Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC),发表于 Eur Respir J。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.
参考来源
- Ong CWM, Migliori GB, Raviglione M, et al. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020. PMID: 32586885. doi:10.1183/13993003.01727-2020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。